Meeting Reports

The 2014 Controlling Cancer Summit Anti-Cancer Therapeutics

Off

ReportBookCoverCancer2014 (2)

 The 2014 Controlling Cancer Summit

Anti-Cancer Therapeutics

Meeting report from the Euroscicon event: 14th May 2014, London, UK

Meeting Chair:

Dr. Ann White, Senior Research Fellow, University of Southampton, UK

Author: Matthew Trendowski

Department of Biology, Syracuse University, NY, USA

Editor: Dr. Astrid Englezou, Euroscicon Ltd

This meeting report summarizes the talks from the third day (14th May 2014) of Euroscicon’s The 2014 Controlling Cancer Summit, which described anti-cancer therapeutics

Buy from[amazon asin=B00Q3808KA&text=Amazon]

Contents

ABSTRACT

INTRODUCTION

Selected talks

The selective targeting of cell survival pathways in cancer cells

Early oncology drug development – current strategies and future challenges

Translating antibodies engineered with IgE Fc regions to elicit enhanced effector functions for cancer therapy

Patient delay in accessing breast cancer care in a LIC

In vivo drug combination effects of 1’s-1’-acetoxychavicol acetate (ACA) and 1’s-1’-acetoxyeugenol acetate (AEA) from Alpinia conchigera on human breast and oral cancer xenografts

Investigating the efficacy of combining thymoquinone with clinical drugs to enhance cell death in adult t-cell leukemia

The promise of sonodynamic therapy: using ultrasonic irradiation and chemotherapeutic agents as a treatment modality

Reporter bioassay: a novel, bioluminescent cell-based assay for quantifying Fc effector function of therapeutic antibodies

HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation

FKBPL and peptide derivatives and their dual anti-angiogenic and anti-cancer stem cell activity

Targeting leukaemic stem cells to improve treatment of chronic myeloid leukemia

Discussion panel

CONCLUSION

REFERENCES

BIOGRAPHIES

POSTER PRESENTATION

TARGETING INTEGRIN LINKED KINASE ABOLISHES THE PRESENCE OF MOLECULAR AND PHENOTYPIC MARKERS OF EPITHELIAL-MESENCHYMAL TRANSITION

 

  • File Size: 946 KB
  • Print Length: 32 pages
  • Simultaneous Device Usage: Unlimited
  • Publisher: HONNAO (November 23, 2014)
  • Sold by: Amazon Digital Services,  Inc.
  • Language: English
  • ASIN: B00Q3808KA

Latest Euroscicon Tweets

Error: You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: https://developer.twitter.com/en/portal/product